Notably, the intravenous injection of recombinant MANF-Fc reduces obesity and related metabolic abnormalities by increasing thermogenesis in both HFD-induced and ob/ob obese mouse models. Here, MANF is linked to obesity due to melanocortin 4 receptor deficiency.